Medical Properties Buy Hold or Sell Recommendation

MPW -- USA Stock  

Fiscal Quarter End: December 31, 2019  

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding Medical Properties Trust is 'Strong Hold'. Macroaxis provides Medical Properties buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MPW positions. The advice algorithm takes into account all of Medical Properties Trust available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from MPW buy-and-hold prospective. Please see also Medical Properties Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell Medical PropertiesBuy Medical Properties
Strong Hold

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon Medical Properties Trust has a risk adjusted performance of 0.113, jensen alpha of 0.1312, total risk alpha of 0.0116, sortino ratio of 0.0375 and treynor ratio of 0.6697
Our buy, hold, or sell recommendation tool can be used to cross verify current analyst consensus on Medical Properties Trust and to analyze the entity potential to grow in the current economic cycle. To make sure Medical Properties Trust is not overpriced, please verify all Medical Properties Trust fundamentals including its Number of Shares Shorted, Current Ratio, Current Asset, as well as the relationship between EBITDA and Number of Employees . Given that Medical Properties Trust has Price to Earning of 7.46 , we recommend you check Medical Properties market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Medical Properties Trading Alerts and Improvement Suggestions

Medical Properties has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
Over 80.0% of the company shares are owned by institutional investors
Latest headline from www.uspostnews.com: Better Than An Ultra-Growth Stock Medical Properties Trust , Newmont Goldcorp Corporation - US Post News

Medical Properties current analysts recommendations

Target Median Price21.00
Target Mean Price21.13
Recommendation Mean2.00
Target High Price24.00
Number Of Analyst Opinions12
Target Low Price18.50

Medical Properties Returns Distribution Density

Mean Return0.16Value At Risk1.29
Potential Upside1.85Standard Deviation1.26
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Blackrock IncCommon Shares50.8 M994.4 M
Bank Of New York Mellon CorpCommon Shares14 M273.2 M
Massachusetts Financial Services CoCommon Shares13.5 M264 M
Daiwa Securities Group IncCommon SharesM137.7 M
Lsv Asset ManagementCommon Shares6.7 M130.3 M
Russell Investments Group LtdCommon Shares4.1 M79.2 M
Charles Schwab Investment Management IncCommon Shares2.8 M55.2 M

Medical Properties Greeks

α
Alpha over DOW
=0.13
β
Beta against DOW=0.23
σ
Overall volatility
=1.26
Ir
Information ratio =0.046

Medical Properties Volatility Alert

Medical Properties Trust has relatively low volatility with skewness of -1.97 and kurtosis of 8.94. However, we advise all investors to independently investigate Medical Properties Trust to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare Medical Properties to competition

Medical Properties Fundamental Vs Peers

FundamentalsMedical PropertiesPeer Average
Return On Equity0.09 (0.31) 
Return On Asset0.05 (0.14) 
Profit Margin0.52 (1.27) 
Operating Margin86.81 (5.51) 
Current Valuation13.02 B16.62 B
Shares Outstanding446.29 M571.82 M
Shares Owned by Insiders1.04 10.09 
Shares Owned by Institutions79.67 39.21 
Number of Shares Shorted11.24 M4.71 M
Price to Earning7.46 28.72 
Price to Book1.53 9.51 
Price to Sales11.33 11.42 
Revenue751.31 M9.43 B
Gross Profit774.37 M27.38 B
EBITDA652.22 M3.9 B
Net Income965.69 M570.98 M
Cash and Equivalents451.65 M2.7 B
Cash per Share1.01 5.01 
Total Debt4.96 B5.32 B
Debt to Equity100.70 48.70 
Current Ratio9.36 2.16 
Book Value Per Share12.82 1.93 K
Cash Flow from Operations1.39 B971.22 M
Short Ratio3.43 4.00 
Earnings Per Share2.56 3.12 
Price to Earnings To Growth(0.89) 4.89 
Number of Employees7718.84 K
Beta0.55-0.15
Market Capitalization8.51 B19.03 B
Total Asset5.61 B29.47 B
Retained Earnings(73.66 M)9.33 B
Working Capital157.92 M1.48 B
Current Asset324.63 M9.34 B
   Acquisition by Michael Stewart of 45000 shares of Medical Properties subject to Rule 16b-3 [view details]

Medical Properties Market Momentum

Search macroaxis.com